inauguration_biopharmaceutical_production_facility_vienna

Boehringer Ingelheim inaugurates biopharmaceutical production facility in Vienna, AustriaAdds 185,000 litres of biopharmaceutical production capacityHigh degree of digitalization and automation through smart technologies and artificial intelligence applicationsMulti-product setup enables production of a large variety of molecule formatsInvestment of more than 700 million EUR, creating 500 new jobs

Source: Boehringer Ingelheim Corporate News - October 5, 2021 Category: Research Source Type: news